Hims & Hers Health (HIMS) Interest & Investment Income (2019 - 2020)

Hims & Hers Health (HIMS) reported Interest & Investment Income of $36858.0 for Q2 2020, down 97.67% sequentially from $1.6 million in Q1 2020.

Hims & Hers Health (HIMS) Interest & Investment Income (2019 - 2020) Analysis & Trends

Hims & Hers Health (HIMS) has 2 years of Interest & Investment Income data on file, last reported at $36858.0 in Q2 2020.

For the quarter ending Q2 2020, Interest & Investment Income changed N/A year-over-year to $36858.0; the trailing twelve-month figure through Jun 2020 stood at $4.4 million (changed N/A YoY), and the FY2019 full-year result was $1.9 million, changed N/A from the prior year.
Interest & Investment Income declined to $36858.0 in Q2 2020, from $1.6 million in the prior quarter.
In the past five years, Interest & Investment Income ranged from a high of $1.9 million in Q4 2019 to a low of $36858.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Haleon	88.07 Bn	86.20 Bn	-	-
2	Teva Pharmaceutical Industries	35.75 Bn	32.01 Bn	1.97 Bn	-
3	Zoetis	31.84 Bn	29.90 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	27.18 Bn	23.12 Bn	4.39 Bn	32.85 Mn
5	United Therapeutics	23.09 Bn	20.93 Bn	648.10 Mn	41.80 Mn
6	RedHill Biopharma	21.32 Bn	21.32 Bn	-	-
7	Viatris	19.96 Bn	18.16 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.66 Bn	16.34 Bn	800.70 Mn	28.10 Mn
9	Elanco Animal Health	12.44 Bn	12.02 Bn	785.00 Mn	-
10	Hims & Hers Health	6.44 Bn	5.69 Bn	396.79 Mn	-

Download Data